•The expressions of other genes that are not included in the potential main pathway of steroids' anti-inflammatory effects, yet affected by steroid binding and its receptors, i.e., DUSP-1, JAK-1 and MAPK-1, were dramatically higher in mild COVID-19 patients. The gene discussed is MAPK1; the disease is COVID-19.